Aprea Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:APRE Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
30 Jan 26	BuyUS$5,073	John Hamill	Individual	5,700	US$0.89
30 Jan 26	BuyUS$25,009	Oren Gilad	Individual	28,100	US$0.89
10 Dec 25	BuyUS$5,825	John Hamill	Individual	5,000	US$1.17
10 Dec 25	BuyUS$25,000	Marc Duey	Individual	21,459	US$1.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of APRE?
Owner Type	Number of Shares	Ownership Percentage
Institutions	1,231,869	10.3%
VC/PE Firms	1,271,080	10.6%
Individual Insiders	1,400,802	11.7%
Hedge Funds	2,286,621	19.1%
General Public	5,792,404	48.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 116.6%.

Top Shareholders

Top 25 shareholders own 51.55% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.6%	Soleus Capital LLC	1,271,080	US$1.1m	0%	3.56%
10.6%	Soleus Capital Management, L.P.	1,271,080	US$1.1m	0%	0.04%
8.48%	Aigh Capital Management, LLC	1,015,541	US$906.5k	174%	0.11%
5.69%	Laurence Lytton	681,837	US$608.6k	0%	no data
3.04%	Oren Gilad	364,312	US$325.2k	8.79%	no data
2.92%	Vestal Point Capital, LP	350,000	US$312.4k	0%	0.01%
2.25%	Sphera Funds Management Ltd	270,000	US$241.0k	0%	0.03%
2.13%	Marc Duey	255,712	US$228.2k	0%	no data
1.72%	Nantahala Capital Management, LLC	205,760	US$183.7k	0%	0.01%
0.99%	Geode Capital Management, LLC	119,131	US$106.3k	191%	no data
0.5%	Scientech Research LLC	60,281	US$53.8k	0%	0.04%
0.36%	Bernd Seizinger	43,685	US$39.0k	0%	no data
0.33%	BNP Paribas Financial Markets SNC	39,817	US$35.5k	45.7%	no data
0.32%	Vanguard Fiduciary Trust Company	38,464	US$34.3k	0%	no data
0.23%	John Hamill	27,825	US$24.8k	57.9%	no data
0.21%	Renaissance Technologies LLC	25,100	US$22.4k	0%	no data
0.19%	Morgan Stanley	22,330	US$19.9k	-71%	no data
0.18%	LPL Financial LLC	21,052	US$18.8k	-19.2%	no data
0.16%	Vanguard Capital Management, LLC	19,622	US$17.5k	0%	no data
0.15%	Rifat Pamukcu	17,464	US$15.6k	0%	no data
0.12%	HighTower Advisors, LLC	13,864	US$12.4k	0%	no data
0.11%	Two Sigma Securities, LLC	13,500	US$12.0k	0%	no data
0.11%	Susquehanna International Group, LLP	13,018	US$11.6k	0%	no data
0.071%	BlackRock, Inc.	8,504	US$7.6k	0%	no data
0.068%	John Henneman	8,139	US$7.3k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/31 08:23
End of Day Share Price	2026/05/29 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aprea Therapeutics, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Esther Lannie Hong	Berenberg
Joseph Pantginis	H.C. Wainwright & Co.
Jason McCarthy	Maxim Group